Barbara Cipriani
Company: Pathios Therapeutics
Job title: Vice President, Biology
Seminars:
Validation of GPR65 as a Novel Immuno-oncology Target using Advanced In Vitro & In Vivo Models 4:30 pm
Identification of GPR65 as a novel immuno-oncology target as well as potent GPR65 inhibitors Provide additional validation using primary tumorhistocultures and genetically engineered mice Advancing biomarker development to accelerate clinical developmentRead more
day: Day One PM
TRACK A: Target ID & Validation 10:35 am
day: Day One Track A AM